SARUDBHAVA FORMULATIONS PRIVATE LTD has a total of 18 patent applications. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are UMBERT MILLET IGNACIO, BIOFRONTERA BIOSCIENCE GMBH and BIONORICA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 2 | |
#7 | China | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sreedharala Venkata Nookaraju | 14 |
#2 | Venkata Nookaraju Sreedharala | 4 |
#3 | Kalakoti Srikanth | 3 |
#4 | Manakkote Ramdas | 2 |
#5 | Yelchuri Vijaya Rajesh Kumar | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020170268A1 | Apremilast lipophilic topical pharmaceutical compositions | |
WO2020095319A1 | Teriflunomide topical pharmaceutical compositions | |
WO2020058992A1 | Improved and stable apremilast pharmaceutical compositions | |
WO2019123476A1 | Stable amorphous eliglustat premix and process for the preparation thereof | |
WO2019030773A1 | Low-dose diclofenac compositions | |
CN110352052A | The local treatment composition of Apremilast | |
CA3018969A1 | Apremilast pharmaceutical compositions |